# Astellas Venture Management: portfolio, investments and team > Astellas Venture Management is a corporate vc based in United States. 29 investments on record, 1 in the last 12 months, latest Apr 2026. Source: https://millionrounds.com/fund/astellas-venture-management (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Astellas Venture Management Last cheque observed Apr 2026; 29 cheques on record. Email Deploying now Corporate VC Pre-seed Seed Series A Therapeutics Platform Technologies Follow Astellas Venture Management and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fastellas-venture-management) Deploying now **100%** of best year **1** **cheques in 12 months**, 29 on record Since the last cheque **206** days **00** hrs **00** min **00** sec Median round **$24M** Rounds led **0 of 29** Sole investor **1 rounds** Exits **3 from the portfolio** Mostly in **United States, 62%** Pitch Astellas Venture Management ## Astellas Venture Management highlights - 01 1 cheques in the last 12 months - 02 Mostly Series B and Series A: 69% of its rounds - 03 Sole investor in 1 rounds, median undisclosed - 04 3 exits from the portfolio ## What they do > AVM is the wholly-owned venture capital organization within Astellas, dedicated to supporting pre-clinical, cutting-edge science that can bring VALUE to patients. From their own website - **Type:** Corporate VC - **Cheque size:** Not stated - **Stages:** Pre-seed Seed Series A - **Sectors:** Therapeutics Platform Technologies - **Based in:** London, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **29 appearances** - **2026** 1 round - **Apr** **[Sidewinder Therapeutics](https://millionrounds.com/company/sidewinder-therapeutics)** Series B · US · Ventureburn **$137M** With 8 others - **2021** 1 round - **Mar** **[NeoPhore Limited](https://millionrounds.com/company/neophore-limited)** Series B · GB · Firms' own news pages **$21M** With 4 others - **2019** 2 rounds - **Nov** **[Heartseed](https://millionrounds.com/company/heartseed)** Series B · JP · FinSMEs **$26M** With 4 others - **Aug** **[Cleave Therapeutics](https://millionrounds.com/company/cleave-therapeutics)** Series C · US · Businesswire **$12M** With 8 others - **2014** 5 rounds - **Dec** **[Crescendo Biologics](https://millionrounds.com/company/crescendo-biologics)** Venture · GB **Undisclosed** Sole investor - **Oct** **[Viamet Pharmaceuticals](https://millionrounds.com/company/viamet-pharmaceuticals)** Series D · US **$60M** With 4 others - **Oct** **[Raze Therapeutics](https://millionrounds.com/company/raze-therapeutics)** Series A · US **$24M** With 6 others - **Oct** **[Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics)** Series A · GB **$32M** With 4 others - **Apr** **[Crescendo Biologics](https://millionrounds.com/company/crescendo-biologics)** Series A · GB **$3.0M** With 3 others - **2013** 4 rounds - **Dec** **[Crescendo Biologics](https://millionrounds.com/company/crescendo-biologics)** Series A · GB **$27M** With 2 others - **May** **[Effector Therapeutics](https://millionrounds.com/company/effector-therapeutics)** Series A · US · fiercebiotech.com **$45M** With 6 others - **Feb** **[DecImmune Therapeutics](https://millionrounds.com/company/decimmune-therapeutics)** Growth · US · finsmes.com **$2.3M** With 2 others - **Jan** **[Cleave Biosciences](https://millionrounds.com/company/cleave-biosciences)** Growth · US **$15M** With 5 others - **2012** 3 rounds - **Dec** **[Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics)** GB · finsmes.com **$6.0M** With 4 others - **Sept** **[F2G](https://millionrounds.com/company/f2g)** Venture · GB · fiercebiotech.com **$30M** With 6 others - **Jun** **[PhaseBio Pharmaceuticals](https://millionrounds.com/company/phasebio-pharmaceuticals)** Series B · US · pevc.dowjones.com **$23M** With 4 others - **2011** 3 rounds - **Oct** **[Cleave Biosciences](https://millionrounds.com/company/cleave-biosciences)** Series A · US · finsmes.com **$44M** With 5 others - **Jul** **[Verastem](https://millionrounds.com/company/verastem)** Series B · US · masshightech.com **$32M** With 5 others - **May** **[Fate Therapeutics](https://millionrounds.com/company/fate-therapeutics)** Series B · US · sec.gov **$36M** With 5 others - **2010** 2 rounds - **Sept** **[DecImmune Therapeutics](https://millionrounds.com/company/decimmune-therapeutics)** Venture · US · finsmes.com **$3.2M** With 2 others - **Jun** **[Nereus Pharmaceuticals](https://millionrounds.com/company/nereus-pharmaceuticals)** Series E · US · onbiovc.com **$20M** With 6 others - **2009** 3 rounds - **Oct** **[Epizyme](https://millionrounds.com/company/epizyme)** Series B · US · fiercebiotech.com **$32M** With 4 others - **Jul** **[Viamet Pharmaceuticals](https://millionrounds.com/company/viamet-pharmaceuticals)** Series B · US · sec.gov **$25M** With 6 others - **Jan** **[Intradigm Corporation](https://millionrounds.com/company/intradigm-corporation)** Series B · US · fiercebiotech.com **$21M** With 7 others - **2008** 2 rounds - **Aug** **[F2G](https://millionrounds.com/company/f2g)** Venture · GB · f2g.com **$12M** With 3 others - **Jun** **[Inimex Pharmaceuticals](https://millionrounds.com/company/inimex-pharmaceuticals)** Series B · CA **$22M** With 7 others - **2007** 1 round - **Aug** **[Nereus Pharmaceuticals](https://millionrounds.com/company/nereus-pharmaceuticals)** Series D · US **$45M** With 12 others - **2006** 2 rounds - **Sept** **[CoMentis](https://millionrounds.com/company/comentis)** Series B · US **$50M** With 4 others - **Feb** **[Lectus Therapeutics](https://millionrounds.com/company/lectus-therapeutics)** Series A · GB · lectustherapeutics.com **$14M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **5** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **3 in all** **[Verastem](https://millionrounds.com/company/verastem)** Listed **$52M** Jul 2013 **[Epizyme](https://millionrounds.com/company/epizyme)** Listed **$60M** May 2013 **[Intradigm Corporation](https://millionrounds.com/company/intradigm-corporation)** Bought by [Silence Therapeutics](https://millionrounds.com/fund/silence-therapeutics) **Undisclosed** Dec 2009 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Pre-seed Seed Series A Median round joined **$24M** the round, not its cheque Alone, median **-** Led 0 of 29 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Apr 2026 - **Exits:** 3 from the portfolio Rounds by stage said on their site - Series B *11* - Series A said *7* - Venture *4* - Growth *2* - Series D *2* - Pre-seed said *-* - Seed said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) 8 - [OrbiMed](https://millionrounds.com/fund/orbimed) 4 - [Roche Venture Fund](https://millionrounds.com/fund/roche-venture-fund) 4 - [U.S. Venture Partners](https://millionrounds.com/fund/u-s-venture-partners-usvp) 4 - [5AM Ventures](https://millionrounds.com/fund/5am-ventures) 3 - [Alta Partners](https://millionrounds.com/fund/alta-partners) 3 **Pitching Astellas Venture Management?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Astellas Venture Management. A count of rooms they were both in, not a relationship either has claimed. [**Novartis Venture Fund** Corporate VC **8** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**OrbiMed** Private equity **4** rounds together](https://millionrounds.com/fund/orbimed)[**Roche Venture Fund** Corporate VC **4** rounds together](https://millionrounds.com/fund/roche-venture-fund)[**U.S. Venture Partners** VC firm **4** rounds together](https://millionrounds.com/fund/u-s-venture-partners-usvp)[**5AM Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/5am-ventures)[**Alta Partners** VC firm **3** rounds together](https://millionrounds.com/fund/alta-partners)[**Atlas Venture** VC firm **3** rounds together](https://millionrounds.com/fund/atlas-venture)[**Clarus Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/blackstone)[**Hatteras Venture Partners** VC firm **3** rounds together](https://millionrounds.com/fund/hatteras-venture-partners)[**MPM Capital** Private equity **3** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**New Enterprise Associates** VC firm **3** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Osage University Partners** VC firm **3** rounds together](https://millionrounds.com/fund/osage-university-partners) ## Recently backed The latest companies Astellas Venture Management put money into. [**Sidewinder Therapeutics** $137M · Apr 2026](https://millionrounds.com/company/sidewinder-therapeutics)[**Heartseed** $26M · Nov 2019](https://millionrounds.com/company/heartseed)[**Cleave Therapeutics** $12M · Aug 2019](https://millionrounds.com/company/cleave-therapeutics) ## Quick answers about Astellas Venture Management ### What does Astellas Venture Management invest in? Astellas Venture Management invests most often at Series B and Series A (69% of the rounds on record), in sectors such as Therapeutics and Platform Technologies. ### How active is Astellas Venture Management? 29 investments on record, 1 of them in the last 12 months. The most recent was in Apr 2026. ### What has Astellas Venture Management invested in recently? Its most recent investments on record: Sidewinder Therapeutics (Series B, Apr 2026), NeoPhore Limited (Series B, Mar 2021) and Heartseed (Series B, Nov 2019). ### How big are Astellas Venture Management's cheques? The median round it joins is $24M. ### Does Astellas Venture Management lead rounds? Rarely, if at all: none of its 29 investments on record names it as the lead. ### Where does Astellas Venture Management invest? Most of the companies it backs are in the United States (62%) and the United Kingdom (31%). ### Is Astellas Venture Management investing now? Yes: it is actively investing, with 1 investments in the last 12 months. ### Who does Astellas Venture Management invest alongside? Most often Novartis Venture Fund (8 rounds together), OrbiMed (4 rounds together) and Roche Venture Fund (4 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=astellas-venture-management) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=astellas-venture-management)